Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.58
+0.22 (4.10%)
At close: Apr 28, 2026, 4:00 PM EDT
5.40
-0.18 (-3.23%)
After-hours: Apr 28, 2026, 4:48 PM EDT
Atea Pharmaceuticals Employees
Atea Pharmaceuticals had 55 employees as of December 31, 2025. The number of employees decreased by 1 or -1.79% compared to the previous year.
Employees
55
Change (1Y)
-1
Growth (1Y)
-1.79%
Revenue / Employee
n/a
Profits / Employee
-$2,879,073
Market Cap
444.57M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| REGENXBIO | 371 |
| Aura Biosciences | 113 |
| Prelude Therapeutics | 79 |
| Assembly Biosciences | 73 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
| Candel Therapeutics | 55 |
AVIR News
- 5 weeks ago - Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Benzinga
- 7 weeks ago - Atea Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call on March 5, 2026 - GlobeNewsWire
- 2 months ago - Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026 - GlobeNewsWire
- 3 months ago - Atea Pharmaceuticals Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire